{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "UCH-L1",
        "Protein_Change": {
          "ref": "I",
          "alt": "M",
          "position": "93"
        },
        "variant_string_id": "UCH-L1 I93M"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper defines the disease mechanism as involving the secretion of UCH-L1, which is altered by the I93M mutation, potentially contributing to Parkinson's disease pathology.",
          "judgment": "Yes",
          "reasoning": "The paper clearly links the I93M mutation in UCH-L1 to familial Parkinson's disease, describing its effects on protein secretion and potential role in disease pathology."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses secretion assays to evaluate the effect of the I93M mutation on UCH-L1 secretion, a relevant approach given the paper's focus on unconventional protein secretion pathways.",
          "judgment": "Yes",
          "reasoning": "The secretion assays effectively model the disease mechanism by assessing how the mutation affects UCH-L1's secretion, which is directly related to the proposed disease pathology.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper describes the use of controls (wild-type UCH-L1) and replicates (n=3), and the assays are validated by showing differential secretion between wild-type and mutant UCH-L1.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were used, and the assay's validity is supported by the clear differential secretion observed between wild-type and mutant UCH-L1.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study uses wild-type UCH-L1 as a control, which serves as a known benign variant in the context of the assay.",
          "judgment": "Yes",
          "reasoning": "The use of wild-type UCH-L1 as a control provides a baseline for assessing the pathogenic effect of the I93M mutation on secretion.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Statistical analyses (t-test) show significant differences in secretion between wild-type and I93M UCH-L1, supporting the pathogenic effect of the mutation.",
          "judgment": "Yes",
          "reasoning": "The statistical significance of the results supports the pathogenic interpretation of the I93M mutation's effect on UCH-L1 secretion.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study does not calculate OddsPath but uses statistical analysis to show significant differences in secretion.",
          "judgment": "Yes",
          "reasoning": "Although OddsPath is not calculated, the significant statistical differences support a pathogenic interpretation.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The I93M mutation in UCH-L1 is associated with decreased secretion, supported by statistical analysis and control experiments, indicating a moderate level of pathogenic evidence."
    }
  ]
}